Latest

For most organizations, artificial intelligence is still described as a tool. An assistant. A productivity layer. Something advisory rather than authoritative. That description is already false. Across regulated and commercial environments, AI outputs are being copied into reports, summarized in emails, referenced in decision rationales, surfaced to customers, and relied

AIVO Journal — Governance Commentary On January 2, 2026, The Guardian reported multiple cases in which Google’s AI Overviews delivered misleading or potentially harmful health information to users. The examples were unexceptional: dietary guidance presented to pancreatic cancer patients, interpretations of liver test results, and descriptions of routine screening procedures.

When AI-mediated decisions can be reconstructed, failing to do so becomes a governance choice A routine incident A customer contacts support to challenge a recommendation they received from an AI assistant. The assistant had explained why a particular product was suitable, summarized key risks, and ruled out alternatives. The

AIVO Journal — Governance Case Study (2026) Executive summary By 2026, AI failures in regulated environments are no longer edge cases. They are operational facts. What distinguishes resilient organizations from exposed ones is not whether failures occur, but whether those failures are inspectable, attributable, and governable after the fact. This article

Why the SEC Investor Advisory Committee Has Created an Evidentiary Gap AIVO Journal — Governance Commentary On December 4, 2025, the SEC Investor Advisory Committee approved a recommendation urging the Commission to consider a disclosure framework addressing the impact of artificial intelligence on issuer operations. The recommendation is non-binding, but

When AI-Mediated Suitability Claims Become a Governance Failure AIVO Journal — Sector Governance Analysis (Financial Services) Executive Summary Public-facing AI assistants increasingly provide guidance to consumers on financial products, risks, suitability, and comparative options. These outputs often appear in high-intent contexts and are relied upon as synthesized judgments

When Omitted Contraindications Become a Pharmacovigilance Failure AIVO Journal — Sector Governance Analysis (Pharma & Life Sciences) Executive Summary AI assistants now provide medication guidance to patients and caregivers at scale, often before consultation with healthcare professionals or review of approved labeling. These systems are not neutral information channels. They actively